Orchestra BioMed Holdings (OBIO) Change in Cash (2021 - 2026)

Orchestra BioMed Holdings (OBIO) has 6 years of Change in Cash data on file, last reported at -$6.3 million in Q1 2026.

• On a quarterly basis, Change in Cash fell 61.59% year-over-year to -$6.3 million in Q1 2026; TTM through Mar 2026 was $10.0 million, a 301.35% increase from a year earlier, with the FY2025 full-year figure at $12.4 million, up 249.78% from the prior year.
• Change in Cash for Q1 2026 stood at -$6.3 million, up from -$7.3 million in the prior quarter.
• Over the last five years, Change in Cash for OBIO reached as high as $77.6 million in Q2 2022 and fell as low as -$77.2 million in Q4 2022.
• Historically, Change in Cash has averaged $1.1 million across 5 years, with a median of -$1.1 million in 2023.
• On a YoY basis, Change in Cash climbed as much as 198454.75% in 2022 and fell as far as 267668.34% in 2022.
• Year by year, Change in Cash stood at -$77.2 million in 2022, then jumped by 114.87% to $11.5 million in 2023, then sank by 129.13% to -$3.3 million in 2024, then plunged by 118.96% to -$7.3 million in 2025, then gained by 13.64% to -$6.3 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were -$6.3 million in Q1 2026, -$7.3 million in Q4 2025, and $23.3 million in Q3 2025.